Company profile: IPA
1.1 - Company Overview
Company description
- Provider of bioplatform-based, AI-driven antibody discovery and development services leveraging systems biology and multi-omics modeling. Offerings include target analysis and immunization, antibody discovery and characterization (sequencing and custom assays), developability profiling, and optimization/engineering (humanization, affinity maturation, chimerization). Includes LENSai Integrated Intelligence Technology for drug discovery.
Products and services
- LENSai Integrated Intelligence Technology: An AI-integrated, drug discovery platform that concurrently analyzes biological data across multiple domains to inform antibody discovery decisions using complex artificial intelligence systems
- Full-scale Antibody Discovery and Development: A bioplatform-based, end-to-end program delivering target analysis, immunization, and optimization to advance therapeutic antibody candidates
- Optimization and Engineering: Custom-engineered antibody enhancements performing humanization, affinity maturation, and chimerization to strengthen clinical profiles for therapeutic development
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to IPA
Nutra-Med Packaging
HQ: United States
Website
- Description: Provider of supply chain management and contract packaging for pharmaceutical and healthcare products, offering blister packaging (thermoforming, cold forming, barcode printing), high-speed bottling (glass vials/bottles, labeling, gummy vitamins, serialization/aggregation), secondary assembly and kitting, cartoning, serialization for bottles, blisters and cartons, and cold chain storage with 80 pallet locations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nutra-Med Packaging company profile →
Clinvest Research
HQ: United States
Website
- Description: Provider of clinical research services conducting clinical trials for headache and migraine, arthritis and joint pain, diabetes and weight management, and vaccines (flu, RSV, COVID). Partners with pharmaceutical companies to study and develop new treatments and health strategies, providing participants access to new treatments before they are widely available.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinvest Research company profile →
START Research
HQ: United States
Website
- Description: Provider of oncology and biotechnology research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full START Research company profile →
Pyxa Solutions
HQ: United States
Website
- Description: Provider of consulting, operational, and strategic services supporting life sciences teams.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pyxa Solutions company profile →
Azzur
HQ: United States
Website
- Description: Provider of pharmaceutical, biotechnology, and medical device manufacturing; cGMP-compliant cleanroom space, warehousing, and material management; GxP advisory and consulting; commissioning, qualification, and process/cleaning validation; temperature-mapping equipment rental; aseptic and GxP training via on-site and turnkey centers; and IT advisory services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Azzur company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for IPA
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to IPA
2.2 - Growth funds investing in similar companies to IPA
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for IPA
4.2 - Public trading comparable groups for IPA
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →